AVSF - Cytovale 2024, LLC is a venture capital fund based in Boston, Massachusetts. According to its most recent Form D, filed Oct 28, 2024, it has sold $652,027 of interests to 55 investors since its first sale in Oct 2024. The minimum investment it accepts from an outside investor is $10,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Michael Collins.
- Total raised
- $652,027Cumulative sales reported on Form D
- Investors
- 55
- First sale
- Oct 14, 2024
- Minimum investment
- $10,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Michael Collins
- Latest Form D
- Oct 28, 2024
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about AVSF - Cytovale 2024, LLC
What is the minimum investment for AVSF - Cytovale 2024, LLC?
According to its latest Form D, filed Oct 28, 2024, the minimum investment AVSF - Cytovale 2024, LLC accepts from an outside investor is $10,000.
Who can invest in AVSF - Cytovale 2024, LLC?
AVSF - Cytovale 2024, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has AVSF - Cytovale 2024, LLC raised?
AVSF - Cytovale 2024, LLC reports $652,027 sold from 55 investors on its Form D filed Oct 28, 2024. This is cumulative sales since the offering began, not current assets or performance.
Where is AVSF - Cytovale 2024, LLC based?
AVSF - Cytovale 2024, LLC is based in Boston, Massachusetts.
When did AVSF - Cytovale 2024, LLC launch?
AVSF - Cytovale 2024, LLC reports its first sale in Oct 2024.
Size compared with every venture capital fund
Raised more than 56% of the 533 venture capital funds based in Massachusetts, and more than 54% of all 14,877 that report sales.